{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:38:22Z","timestamp":1776497902178,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10072-021-05100-w","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:59:40Z","timestamp":1612292380000},"page":"3871-3878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Episodic psychosis, ataxia, motor neuropathy with pyramidal signs (PAMP syndrome)\u00a0caused by a novel mutation in ADPRHL2 (AHR3)"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-676X","authenticated-orcid":false,"given":"Hacer","family":"Durmus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Merto\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u015f\u0131n Baral","family":"Kulaks\u0131zo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Hashemolhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evren \u00d6nay","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Parman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"5100_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1478-811X-8-31","volume":"8","author":"GV Chaitanya","year":"2010","unstructured":"Chaitanya GV, Steven AJ, Babu PP (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8:31","journal-title":"Cell Commun Signal"},{"key":"5100_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14802\/jmd.16028","volume":"9","author":"KD Choi","year":"2016","unstructured":"Choi KD, Choi JH (2016) Episodic ataxias: clinical and genetic features. J Mov Disord 9:129\u2013135","journal-title":"J Mov Disord"},{"key":"5100_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.dnarep.2004.06.017","volume":"3","author":"PM Clements","year":"2004","unstructured":"Clements PM, Breslin C, Deeks ED, Byrd PJ, Ju L, Bieganowski P, Brenner C, Moreira MC, Taylor AM, Caldecott KW (2004) The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. DNA repair 3:1493\u20131502","journal-title":"DNA repair"},{"key":"5100_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ajhg.2018.10.005","volume":"103","author":"K Danhauser","year":"2018","unstructured":"Danhauser K, Alhaddad B, Makowski C, Piekutowska-Abramczuk D, Syrbe S, Gomez-Ospina N, Manning MA, Kostera-Pruszczyk A, Krahn-Peper C, Berutti R, Kovacs-Nagy R, Gusic M, Graf E, Laugwitz L, Roblitz M, Wroblewski A, Hartmann H, Das AM, Bultmann E, Fang F, Xu M, Schatz UA, Karall D, Zellner H, Haberlandt E, Feichtinger RG, Mayr JA, Meitinger T, Prokisch H, Strom TM, Ploski R, Hoffmann GF, Pronicki M, Bonnen PE, Morlot S, Haack TB (2018) Bi-allelic ADPRHL2 mutations cause neurodegeneration with developmental delay, ataxia, and axonal neuropathy. Am J Hum Genet 103:817\u2013825","journal-title":"Am J Hum Genet"},{"key":"5100_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature03314","volume":"434","author":"SF El-Khamisy","year":"2005","unstructured":"El-Khamisy SF, Saifi GM, Weinfeld M, Johansson F, Helleday T, Lupski JR, Caldecott KW (2005) Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434:108\u2013113","journal-title":"Nature"},{"key":"5100_CR6","doi-asserted-by":"publisher","first-page":"e28533","DOI":"10.7554\/eLife.28533","volume":"6","author":"P Fontana","year":"2017","unstructured":"Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I (2017) Serine ADP-ribosylation reversal by the hydrolase ARH3. Elife 6:e28533","journal-title":"Elife"},{"key":"5100_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ajhg.2018.10.002","volume":"103","author":"SG Ghosh","year":"2018","unstructured":"Ghosh SG, Becker K, Huang H, Dixon-Salazar T, Chai G, Salpietro V, Al-Gazali L, Waisfisz Q, Wang H, Vaux KK, Stanley V, Manole A, Akpulat U, Weiss MM, Efthymiou S, Hanna MG, Minetti C, Striano P, Pisciotta L, De Grandis E, Altmuller J, Nurnberg P, Thiele H, Yis U, Okur TD, Polat AI, Amiri N, Doosti M, Karimani EG, Toosi MB, Haddad G, Karakaya M, Wirth B, van Hagen JM, Wolf NI, Maroofian R, Houlden H, Cirak S, Gleeson JG (2018) Biallelic mutations in ADPRHL2, encoding ADP-ribosylhydrolase 3, lead to a degenerative pediatric stress-induced epileptic ataxia syndrome. Am J Hum Genet 103:826","journal-title":"Am J Hum Genet"},{"key":"5100_CR8","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1038\/s41467-020-17069-9","volume":"11","author":"H Hanzlikova","year":"2020","unstructured":"Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasova I, Kubovciak J, Sachova J, Hailstone R, Brazina J, Ghosh S, Cirak S, Gleeson JG, Ahel I, Caldecott KW (2020) Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair. Nat Commun 11:3391","journal-title":"Nat Commun"},{"key":"5100_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature20790","volume":"541","author":"NC Hoch","year":"2017","unstructured":"Hoch NC, Hanzlikova H, Rulten SL, Tetreault M, Komulainen E, Ju L, Hornyak P, Zeng Z, Gittens W, Rey SA, Staras K, Mancini GM, McKinnon PJ, Wang ZQ, Wagner JD, Care4Rare Canada C, Yoon G, Caldecott KW (2017) XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature 541:87\u201391","journal-title":"Nature"},{"key":"5100_CR10","doi-asserted-by":"publisher","unstructured":"Idiculla PS, Siddiqui JH (2021) A case of novel CACNA1A mutation causing type 2 episodic ataxia. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. https:\/\/doi.org\/10.1007\/s10072-021-05059-8","DOI":"10.1007\/s10072-021-05059-8"},{"issue":"Pt 2","key":"5100_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/brain\/122.2.247","volume":"122","author":"S Love","year":"1999","unstructured":"Love S, Barber R, Wilcock GK (1999) Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer\u2019s disease. Brain J Neurol 122(Pt 2):247\u2013253","journal-title":"Brain J Neurol"},{"issue":"6","key":"5100_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/ijms17060856","volume":"17","author":"E Markkanen","year":"2016","unstructured":"Markkanen E, Meyer U, Dianov GL (2016) DNA damage and repair in schizophrenia and autism: implications for cancer comorbidity and beyond. Int J Mol Sci 17(6):856","journal-title":"Int J Mol Sci"},{"key":"5100_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146-148","author":"S Martire","year":"2015","unstructured":"Martire S, Mosca L, d'Erme M (2015) PARP-1 involvement in neurodegeneration: a focus on Alzheimer\u2019s and Parkinson\u2019s diseases. Mech Ageing Dev 146-148:53\u201364","journal-title":"Mech Ageing Dev"},{"key":"5100_CR14","doi-asserted-by":"crossref","unstructured":"Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J (2019) PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.\u00a0 JCI Insight 4(4):e124519","DOI":"10.1172\/jci.insight.124519"},{"key":"5100_CR15","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","volume":"30","author":"J Mateo","year":"2019","unstructured":"Mateo J, Lord CJ, Serra V, Tutt A, Balmana J, Castroviejo-Bermejo M, Cruz C, Oaknin A, Kaye SB, de Bono JS (2019) A decade of clinical development of PARP inhibitors in perspective. Ann Oncol 30:1437\u20131447","journal-title":"Ann Oncol"},{"key":"5100_CR16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2741\/3329","volume":"14","author":"W Min","year":"2009","unstructured":"Min W, Wang ZQ (2009) Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front Biosci 14:1619\u20131626","journal-title":"Front Biosci"},{"key":"5100_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/jbc.M510290200","volume":"281","author":"S Oka","year":"2006","unstructured":"Oka S, Kato J, Moss J (2006) Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J Biol Chem 281:705\u2013713","journal-title":"J Biol Chem"},{"key":"5100_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11065-010-9142-x","volume":"20","author":"JD Schmahmann","year":"2010","unstructured":"Schmahmann JD (2010) The role of the cerebellum in cognition and emotion: personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev 20:236\u2013260","journal-title":"Neuropsychol Rev"},{"key":"5100_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cge.13216","volume":"94","author":"C Scholz","year":"2018","unstructured":"Scholz C, Golas MM, Weber RG, Hartmann C, Lehmann U, Sahm F, Schmidt G, Auber B, Sturm M, Schlegelberger B, Illig T, Steinemann D, Hofmann W (2018) Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia-oculomotor apraxia 4 and pilocytic astrocytoma. Clin Genet 94:185\u2013186","journal-title":"Clin Genet"},{"key":"5100_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1963","volume":"7","author":"V Schreiber","year":"2006","unstructured":"Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517\u2013528","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5100_CR21","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.1074\/jbc.RA118.004284","volume":"293","author":"M Wang","year":"2018","unstructured":"Wang M, Yuan Z, Xie R, Ma Y, Liu X, Yu X (2018) Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation. J Biol Chem 293:14470\u201314480","journal-title":"J Biol Chem"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05100-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05100-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05100-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:41:40Z","timestamp":1630694500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05100-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5100"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05100-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The written informed consent was obtained from all subjects prior to participating in these study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}